Open AccessThe impact of pegylated recombinant human growth hormone replacement therapy on glucose and lipid metabolism in children with growth hormone deficiency
Author(s) -
Cencen Wang,
Heqing Huang,
Chen Zhao,
Jiao Zhao,
Runji Xiong,
Runming Jin,
Yan Bai
Publication year - 2021
Publication title -
annals of palliative medicine
Language(s) - English
Resource type - Journals
eISSN - 2224-5839
pISSN - 2224-5820
DOI - 10.21037/apm-20-871
Subject(s) - medicine , human growth hormone , lipid metabolism , growth hormone deficiency , growth hormone , endocrinology , recombinant dna , hormone , carbohydrate metabolism , biochemistry , chemistry , gene
This study aimed to investigate the impact of pegylated recombinant human growth hormone (PEG-rhGH) replacement therapy on glucose and lipid metabolism in children with growth hormone deficiency (GHD).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom